Urinary PAH and its metabolites as molecular biomarkers of asphalt fume exposure characterized by microflow LC coupled to hybrid quadruple time-of-flight mass spectrometry.
Public Domain
-
2003/06/01
-
Details
-
Personal Author:Afshari A ; Frazer D ; Goldsmith T ; Law B ; Lewis, Daniel M. ; Moseley A ; Simpson J ; Stone S ; Wang JJ
-
Description:Prolonged, extensive exposure to asphalt fume has been associated with several adverse health effects. To study the molecular biomarkers of the effects, a microflow liquid chromatography (LC) coupled to hybrid quadrupole orthogonal acceleration time-of-flight mass spectrometry (Q-TOF MS) was used to develop a bioanalytical method to characterize benzo(a)pyrene and its hydroxy-metabolites from the urine of asphalt fume exposed rats. In the experiment, sixteen Sprague Dawley rats were exposed to asphalt fume in a whole body inhalation chamber for 10 days (4 h/day) and other eight rats were used as controls. The asphalt fume was generated at 150degrees-C and the concentrations in the animal exposure chamber ranged 76-117 mg/m3. Benzo(a)pyrene and its metabolites of 3-hydroxybenzo(a)pyrene, benzo(a)pyrene-7,8-dihydrodiol(+/-), and benzo(a)pyrene-7,8,9,10- tetrahydrotetrol(+/-) were determined 2.19 ng/100 mL, 16.17 ng/100 mL, 6.28 ng/100 mL, and 29.35 ng/100 mL respectively from the urine of asphalt fume exposed rats. The results indicated that the benzo(a)pyrene and its hydroxy-metabolites in the urine of exposed rats were significantly higher than those from the control groups. The approach, which combined microflow LC separation and collision-induced dissociation for leading to a characteristic fragmentation pattern by hybrid Q-TOF MS, offered a distinct advantage for metabolites identification. The new method was sensitive, selective, and applicable toward the study molecular biomarkers of adverse health effects of occupationally related exposure to PAH hazards. The information obtained from these studies may assist prevent occupational illness by utilizing biomarkers of exposure to determine the need to eliminate or minimize exposure.
-
Subjects:
-
Keywords:
-
Publisher:
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:92
-
NIOSHTIC Number:nn:20023372
-
Citation:Working Partnerships: Applying Research to Practice, NORA Symposium 2003, June 23-24, 2003, Arlington, Virginia. Washington, DC: National Institute for Occupational Safety and Health, 2003 Jun; :92
-
CAS Registry Number:
-
Federal Fiscal Year:2003
-
NORA Priority Area:
-
Peer Reviewed:False
-
Source Full Name:Working Partnerships: Applying Research to Practice, NORA Symposium 2003, June 23-24, 2003, Arlington, Virginia
-
Collection(s):
-
Main Document Checksum:urn:sha-512:850bbfb1bb9110983c499bcc56f919d7a0a0859d8636efae5bcf33b82682cd2fe83aaf6c505ab3cae8770fae71515ec5cea008d27ce68f872486ec7e3ea825e6
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like